Original Literature | Model OverView |
---|---|
Publication
Title
A role for caspases in the differentiation of erythroid cells and macrophages.
Affiliation
INSERM, UMR 866, F-21079 Dijon, France.
Abstract
Several cysteine proteases of the caspase family play a central role in manyforms of cell death by apoptosis. Other enzymes of the family are involved incytokine maturation along inflammatory response. In recent years, severalcaspases involved in cell death were shown to play a role in other cellularprocesses such as proliferation and differentiation. In the present review, wesummarize the current knowledge of the role of caspases in the differentiationof erythroid cells and macrophages. Based on these two examples, we show thatthe nature of involved enzymes, the pathways leading to their activation inresponse to specific growth factors, and the specificity of the target proteinsthat are cleaved by the activated enzymes strongly differ from one cell type toanother. Deregulation of these pathways is thought to play a role in thepathophysiology of low-grade myelodysplastic syndromes, characterized byexcessive activation of caspases and erythroid precursor apoptosis, and that ofchronic myelomonocytic leukemia, characterized by a defective activation ofcaspases in monocytes exposed to M-CSF, which blocks their differentiation.
PMID
17905508
|
Entity
NF-kappaB
--
MO000000058
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m69
10
infinite
0
TRANSPATH | MO000000058 |
--
Caspase-3
--
MO000016924
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1839
10
infinite
0
TRANSPATH | MO000016924 |
--
Cytochrome C
--
MO000016985
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m1889
10
infinite
0
InterPro | IPR002327 |
TRANSPATH | MO000016985 |
--
Caspase-9
--
MO000016987
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1891
10
infinite
0
TRANSPATH | MO000016987 |
--
PAK2
--
MO000017616
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2394
10
infinite
0
TRANSPATH | MO000017616 |
--
proCaspase-8
--
MO000017669
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2432
10
infinite
0
InterPro | IPR001309 |
TRANSPATH | MO000017669 |
--
proCaspase-2
--
MO000017670
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m2433
10
infinite
0
InterPro | IPR001309 |
TRANSPATH | MO000017670 |
--
proCaspase-3
--
MO000017671
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m2434
10
infinite
0
InterPro | IPR001309 |
TRANSPATH | MO000017671 |
--
proCaspase-9
--
MO000017811
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2563
10
infinite
0
InterPro | IPR001309 |
TRANSPATH | MO000017811 |
--
proCaspase-7
--
MO000018906
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m3523
10
infinite
0
InterPro | IPR001309 |
TRANSPATH | MO000018906 |
--
alpha-tubulin
--
MO000019238
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m3822
10
infinite
0
TRANSPATH | MO000019238 |
--
Hsp70 {nucleolus}
--
MO000021614
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m5956
10
infinite
0
InterPro | IPR001023 |
TRANSPATH | MO000021614 |
--
proCaspase-6
--
MO000032136
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m11106
10
infinite
0
InterPro | IPR001309 |
TRANSPATH | MO000032136 |
--
GATA-1
--
MO000032476
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m11427
10
infinite
0
InterPro | IPR000679 |
TRANSPATH | MO000032476 |
--
nucleophosmin
--
MO000045126
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m22786
10
infinite
0
TRANSPATH | MO000045126 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
2(small subunit of caspase-3)
--
e11
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m11
0
infinite
0
--
2(small subunit of caspase-6)
--
e12
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m12
0
infinite
0
--
2(large subunit of caspase-7)
--
e13
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m13
0
infinite
0
--
death receptor ligand
--
e14
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m14
0
infinite
0
--
death receptor ligand: Fas
--
e15
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m15
0
infinite
0
--
2(small subunit of caspase-7)
--
e16
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m16
0
infinite
0
--
death receptor ligand: Fas: FADD: proCaspase-8
--
e17
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m17
0
infinite
0
--
csml-variable:Double
m18
0
infinite
0
--
Apaf-1 olgomer: proCaspase-9
--
e19
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
Epo: EpoR: Jak2
--
e20
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m20
0
infinite
0
--
Epo: EpoR dimer: Jak2
--
e21
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m21
0
infinite
0
--
EpoR: Jak2
--
e22
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m22
0
infinite
0
--
Epo: EpoR dimer {p}: Jak2 {p}
--
e23
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m23
0
infinite
0
--
Epo: EpoR dimer: Jak2 {p}
--
e24
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m24
0
infinite
0
--
Epo: EpoR dimer {p}: Jak2 {p}: STAT5
--
e25
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m25
0
infinite
0
--
Epo: EpoR dimer {p}: Jak2 {p}: STAT5 dimer
--
e26
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m26
0
infinite
0
--
Epo: EpoR dimer {p}: Jak2 {p}: STAT5 dimer {p}
--
e27
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m27
0
infinite
0
--
Epo: EpoR dimer {p}: Jak2 {p}: STAT5 dimer {p}: PI3K
--
e28
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m29
0
infinite
0
--
Epo: EpoR dimer {p}: Jak2 {p}: Grb-2
--
e29
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m31
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
Epo: EpoR dimer {p}: Jak2 {p}: Grb-2: Sos
--
e30
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m32
0
infinite
0
--
GATA-1 {activated}
--
e33
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m35
10
infinite
0
InterPro | IPR000679 |
TRANSPATH | MO000032476 |
--
csml-variable:Double
m36
0
infinite
0
--
Hsp70 {nucleolus}: GATA-1
--
e37
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m39
0
infinite
0
--
M-CSF: M-CSF-1-R
--
e39
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m41
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
M-CSF: M-CSF-1-R [p} dimer: PI3K
--
e40
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m42
0
infinite
0
--
M-CSF: M-CSF-1-R [p}
--
e41
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m43
0
infinite
0
--
M-CSF: M-CSF-1-R [p} dimer
--
e42
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m44
0
infinite
0
--
csml-variable:Double
m46
10
infinite
0
Affymetrix | 100132_at |
Ensembl | ENSMUSG00000024590 |
Proteome | HumanPSD/Lmnb1 |
RGD | Lmnb1 |
RefSeq | NM_010721 |
TRANSPATH | MO000085282 |
Unigene | Mm.4105 |
UniProt | P14733 |
--
PARP1 remnants
--
e45
cso30:c:EntityBiological
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m47
0
infinite
0
--
Acinus remnants
--
e46
cso30:c:EntityBiological
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m48
0
infinite
0
--
Lamin-B remnants
--
e47
cso30:c:EntityBiological
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m49
0
infinite
0
--
M-CSF: M-CSF-1-R [p} dimer: proCaspase-8
--
e48
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m63
0
infinite
0
--
M-CSF: M-CSF-1-R [p} dimer: Caspase-8: FADD: RIP1: FLIP-L: FLIP-S
--
e49
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m65
0
infinite
0
--
2(large subunit of caspase-3)
--
e5
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
2(large subunit of caspase-6)
--
e6
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
M-CSF: M-CSF-1-R [p} dimer: Caspase-8
--
e63
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m66
0
infinite
0
--
M-CSF: M-CSF-1-R [p} dimer: Caspase-8: FADD
--
e64
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m67
0
infinite
0
--
RIP1 fragment
--
e65
cso30:c:EntityBiological
cso30:i:CC_Cytosol
--
csml-variable:Double
m68
0
infinite
0
--
NF-kappaB {activated}
--
e66
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m70
10
infinite
0
TRANSPATH | MO000000058 |
--
PAK2 {activated}
--
e67
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m71
10
infinite
0
TRANSPATH | MO000017616 |
--
nucleophosmin {activated}
--
e68
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m72
10
infinite
0
TRANSPATH | MO000045126 |
--
alpha-tubulin remnants
--
e69
cso30:c:EntityBiological
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m73
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
vinculin remnants
--
e70
cso30:c:EntityBiological
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m74
0
infinite
0
--
PAI-2 remnants
--
e71
cso30:c:EntityBiological
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m75
0
infinite
0
--
FLIP-L remnant
--
e73
cso30:c:EntityBiological
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m77
0
infinite
0
--
FLIP-S remnant
--
e74
cso30:c:EntityBiological
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m78
0
infinite
0
--
M-CSF: M-CSF-1-R [p} dimer
--
e75
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m79
0
infinite
0
--
M-CSF: M-CSF-1-R [p} dimer: ERK
--
e76
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m81
0
infinite
0
--
death receptor ligand: Fas: FADD
--
e78
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m83
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c22 : 1
stoichiometry:c138 : 1
stoichiometry:c4 : 1
stoichiometry:c5 : 1
m2434*m21*m66*0.1
nodelay
--
0
PMID: 17905508 those with a short prodomain (procaspase-3, -6 and -7) exist in the cells as dimers that require proteolysis at internal aspartate residues to generate two large and two small subunits whose heterodimerization forms the active enzyme. PMID: 17905508, 14976035, 12438425, 11208865 Caspase-3, together with caspase-9, -7 and -2, are transiently activated during erythroid differentiation induced by Epo and caspase inhibition completely inhibits erythroid differentiation at the basophilic erythroblast stage.
p10
p10
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c26 : 1
stoichiometry:c28 : 1
m14*m580*0.1
nodelay
--
0
PMID: 17905508 Interaction of a death receptor such as Fas (CD95), with its ligand, triggers formation of a death-inducing signaling complex (DISC), including the adaptor molecule FADD, which in turn recruits procaspase-8.
p11
p11
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c20 : 1
stoichiometry:c30 : 1
stoichiometry:c29 : 1
m2432*m83*0.1
nodelay
--
0
PMID: 17905508 Interaction of a death receptor such as Fas (CD95), with its ligand, triggers formation of a death-inducing signaling complex (DISC), including the adaptor molecule FADD, which in turn recruits procaspase-8.
p12
p12
cso30:i:ME_Polymerization
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c21 : 1
stoichiometry:c32 : 1
stoichiometry:c33 : 1
m1889*m1890*0.1
nodelay
--
0
PMID: 17905508 One of the soluble molecules subsequently released in the cytosol is cytochrome c, which induces Apaf-1 (apoptotic protease-activating factor 1) oligomerization and procaspase-9 recruitment and activation in the so-called apoptosome.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c35 : 1
stoichiometry:c34 : 1
stoichiometry:c36 : 1
m2563*m18*0.1
nodelay
--
0
PMID: 17905508 One of the soluble molecules subsequently released in the cytosol is cytochrome c, which induces Apaf-1 (apoptotic protease-activating factor 1) oligomerization and procaspase-9 recruitment and activation in the so-called apoptosome.
p14
p14
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c39 : 1
stoichiometry:c45 : 1
stoichiometry:c40 : 1
m1958*m22*0.1
nodelay
--
0
PMID: 17905508, 8343951 The binding of one Epo molecule to its receptor, which exists as a preformed dimer or dimerizes upon Epo binding, induces a conformational change that activated the constitutively associated JAK2 (Janus family tyrosine protein kinase 2) by transphosphorylation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c41 : 1
stoichiometry:c42 : 1
m20*0.1
nodelay
--
0
PMID: 17905508, 8343951 The binding of one Epo molecule to its receptor, which exists as a preformed dimer or dimerizes upon Epo binding, induces a conformational change that activated the constitutively associated JAK2 (Janus family tyrosine protein kinase 2) by transphosphorylation.
p16
p16
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c38 : 1
stoichiometry:c43 : 1
stoichiometry:c44 : 1
m130*m82*0.1
nodelay
--
0
PMID: 17905508, 8343951 The binding of one Epo molecule to its receptor, which exists as a preformed dimer or dimerizes upon Epo binding, induces a conformational change that activated the constitutively associated JAK2 (Janus family tyrosine protein kinase 2) by transphosphorylation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c46 : 1
stoichiometry:c47 : 1
m21*0.1
nodelay
--
0
PMID: 17905508, 8343951 The binding of one Epo molecule to its receptor, which exists as a preformed dimer or dimerizes upon Epo binding, induces a conformational change that activated the constitutively associated JAK2 (Janus family tyrosine protein kinase 2) by transphosphorylation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c49 : 1
stoichiometry:c50 : 1
m24*0.1
nodelay
--
0
PMID: 17905508 In turn, JAK2 molecules phosphorylate the eight tyrosine residues in the cytoplasmic domain of the Epo receptor, which then serve as docking sites for signaling molecules that contain Src homology 2 (SH2) domains such as STAT5 (Signal Transducer and Activator of Transcription 5), leading to its homodimerization and activation through phosphorylation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c51 : 1
stoichiometry:c52 : 1
stoichiometry:c53 : 1
m1798*m23*0.1
nodelay
--
0
PMID: 17905508 In turn, JAK2 molecules phosphorylate the eight tyrosine residues in the cytoplasmic domain of the Epo receptor, which then serve as docking sites for signaling molecules that contain Src homology 2 (SH2) domains such as STAT5 (Signal Transducer and Activator of Transcription 5), leading to its homodimerization and activation through phosphorylation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c2 : 1
stoichiometry:c6 : 1
stoichiometry:c7 : 1
m11106*0.1
nodelay
--
0
PMID: 17905508 those with a short prodomain (procaspase-3, -6 and -7) exist in the cells as dimers that require proteolysis at internal aspartate residues to generate two large and two small subunits whose heterodimerization forms the active enzyme.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c54 : 1
stoichiometry:c55 : 1
m25*0.1
nodelay
--
0
PMID: 17905508 In turn, JAK2 molecules phosphorylate the eight tyrosine residues in the cytoplasmic domain of the Epo receptor, which then serve as docking sites for signaling molecules that contain Src homology 2 (SH2) domains such as STAT5 (Signal Transducer and Activator of Transcription 5), leading to its homodimerization and activation through phosphorylation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c56 : 1
stoichiometry:c57 : 1
m26*0.1
nodelay
--
0
PMID: 17905508 In turn, JAK2 molecules phosphorylate the eight tyrosine residues in the cytoplasmic domain of the Epo receptor, which then serve as docking sites for signaling molecules that contain Src homology 2 (SH2) domains such as STAT5 (Signal Transducer and Activator of Transcription 5), leading to its homodimerization and activation through phosphorylation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c58 : 1
stoichiometry:c59 : 1
stoichiometry:c60 : 1
m27*m28*0.1
nodelay
--
0
PMID: 17905508 Other active signaling molecules recruited by the phosphorylated Epo receptor include the phopshatidylinositol- 3 kinase that, together with STAT5, promote erythroid cell survival, and son of sevenless protein recruited through the adaptor protein Grb-2 to activate the RAS/MAP (mitogen- activated protein) kinase pathway, thereby promoting proliferation.
p23
p23
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c61 : 1
stoichiometry:c62 : 1
stoichiometry:c63 : 1
m23*m30*0.1
nodelay
--
0
PMID: 17905508 Other active signaling molecules recruited by the phosphorylated Epo receptor include the phopshatidylinositol- 3 kinase that, together with STAT5, promote erythroid cell survival, and son of sevenless protein recruited through the adaptor protein Grb-2 to activate the RAS/MAP (mitogen- activated protein) kinase pathway, thereby promoting proliferation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c64 : 1
stoichiometry:c65 : 1
stoichiometry:c66 : 1
m1720*m31*0.1
nodelay
--
0
PMID: 17905508 Other active signaling molecules recruited by the phosphorylated Epo receptor include the phopshatidylinositol- 3 kinase that, together with STAT5, promote erythroid cell survival, and son of sevenless protein recruited through the adaptor protein Grb-2 to activate the RAS/MAP (mitogen- activated protein) kinase pathway, thereby promoting proliferation.
p25
p25
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c67 : 1
stoichiometry:c70 : 1
stoichiometry:c71 : 1
m32*m1688*0.1
nodelay
--
0
PMID: 17905508 Other active signaling molecules recruited by the phosphorylated Epo receptor include the phopshatidylinositol- 3 kinase that, together with STAT5, promote erythroid cell survival, and son of sevenless protein recruited through the adaptor protein Grb-2 to activate the RAS/MAP (mitogen- activated protein) kinase pathway, thereby promoting proliferation.
p26
p26
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c68 : 1
stoichiometry:c72 : 1
stoichiometry:c69 : 1
m1849*m34*0.1
nodelay
--
0
PMID: 17905508 Other active signaling molecules recruited by the phosphorylated Epo receptor include the phopshatidylinositol- 3 kinase that, together with STAT5, promote erythroid cell survival, and son of sevenless protein recruited through the adaptor protein Grb-2 to activate the RAS/MAP (mitogen- activated protein) kinase pathway, thereby promoting proliferation.
p27
p27
cso30:i:ME_Cleavage
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c76 : 1
stoichiometry:c73 : 1
stoichiometry:c78 : 1
m11427*m1815*0.1
nodelay
--
0
PMID: 17905508, 10359572, 10428030 In Epo-deprived as well as Fas-ligand treated immature erythroblasts, activated caspases cleave the transcription factor GATA-1. This transcription factor mediates Epo-induced up-regulation of the anti-apoptotic protein Bcl-XL.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c75 : 1
stoichiometry:c90 : 1
stoichiometry:c77 : 1
m11427*m37*0.1
nodelay
--
0
PMID: 17905508, 10359572, 10428030 In Epo-deprived as well as Fas-ligand treated immature erythroblasts, activated caspases cleave the transcription factor GATA-1. This transcription factor mediates Epo-induced up-regulation of the anti-apoptotic protein Bcl-XL. PMID: 17905508, 14976035, 12438425, 11208865 Caspase-3, together with caspase-9, -7 and -2, are transiently activated during erythroid differentiation induced by Epo and caspase inhibition completely inhibits erythroid differentiation at the basophilic erythroblast stage.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c74 : 1
stoichiometry:c79 : 1
m35*0.1
nodelay
--
0
PMID: 17905508, 10359572, 10428030 In Epo-deprived as well as Fas-ligand treated immature erythroblasts, activated caspases cleave the transcription factor GATA-1. This transcription factor mediates Epo-induced up-regulation of the anti-apoptotic protein Bcl-XL.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c3 : 1
stoichiometry:c19 : 1
stoichiometry:c8 : 1
stoichiometry:c9 : 1
m3523*m21*0.1
nodelay
--
0
PMID: 17905508 those with a short prodomain (procaspase-3, -6 and -7) exist in the cells as dimers that require proteolysis at internal aspartate residues to generate two large and two small subunits whose heterodimerization forms the active enzyme. PMID: 17905508, 14976035, 12438425, 11208865 Caspase-3, together with caspase-9, -7 and -2, are transiently activated during erythroid differentiation induced by Epo and caspase inhibition completely inhibits erythroid differentiation at the basophilic erythroblast stage.
p30
p30
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c83 : 1
stoichiometry:c85 : 1
stoichiometry:c84 : 1
m2563*m21*0.1
nodelay
--
0
PMID: 17905508, 14976035, 12438425, 11208865 Caspase-3, together with caspase-9, -7 and -2, are transiently activated during erythroid differentiation induced by Epo and caspase inhibition completely inhibits erythroid differentiation at the basophilic erythroblast stage.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c86 : 1
stoichiometry:c88 : 1
m1839*0.1
nodelay
--
0
PMID: 17905508 Along erythroid differentiation, activated caspase-3 and, to a lower extent, caspase-7, are found in the nucleus where they co-localize with GATA-1 but this transcription factor is protected from caspase-mediated proteolysis through interaction with the chaperone heat shock protein Hsp70.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c87 : 1
stoichiometry:c89 : 1
m2382*0.1
nodelay
--
0
PMID: 17905508 Along erythroid differentiation, activated caspase-3 and, to a lower extent, caspase-7, are found in the nucleus where they co-localize with GATA-1 but this transcription factor is protected from caspase-mediated proteolysis through interaction with the chaperone heat shock protein Hsp70.
p34
p34
cso30:i:ME_Binding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c94 : 1
stoichiometry:c95 : 1
stoichiometry:c96 : 1
m11427*m5956*0.1
nodelay
--
0
PMID: 17905508 Along erythroid differentiation, activated caspase-3 and, to a lower extent, caspase-7, are found in the nucleus where they co-localize with GATA-1 but this transcription factor is protected from caspase-mediated proteolysis through interaction with the chaperone heat shock protein Hsp70.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c98 : 1
stoichiometry:c99 : 1
m5956*0.1
nodelay
--
0
PMID: 17905508 Epo starvation induces Hsp70 nucleus export and exposes GATA-1 to caspase-mediated cleavage.
p36
p36
cso30:i:ME_Translocation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c97 : 1
stoichiometry:c101 : 1
stoichiometry:c100 : 1
m40*m20*0.1
nodelay
--
0
PMID: 17905508 In the presence of Epo, Hsp70 migrates in the nucleus when caspases are activated and protect GATA-1 from caspase-mediated cleavage.
p37
p37
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c102 : 1
stoichiometry:c103 : 1
stoichiometry:c104 : 1
m89*m1031*0.1
nodelay
--
0
PMID: 17905508 The growth factor M-CSF/CSF-1 is a disulfide-linked homodimer that binds to CSF-1 receptor, stabilizes its non-covalent dimerization, activates its kinase activity and stimulates its tyrosine phosphorylation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c105 : 1
stoichiometry:c106 : 1
m41*0.1
nodelay
--
0
PMID: 17905508 The growth factor M-CSF/CSF-1 is a disulfide-linked homodimer that binds to CSF-1 receptor, stabilizes its non-covalent dimerization, activates its kinase activity and stimulates its tyrosine phosphorylation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c107 : 1
stoichiometry:c108 : 1
m43*0.1
nodelay
--
0
PMID: 17905508, 12966146 This limited phosphorylation induces the covalent dimerization of the receptor through disulfide binding, which activates a second wave of tyrosine phosphorylation of the receptor and its interaction with downstream signaling molecules that include phosphatidylinositol- 3-kinases, extracellular-signal-related kinases and Src kinases.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c11 : 1
stoichiometry:c16 : 1
m5*m11*0.1
nodelay
--
0
PMID: 17905508 those with a short prodomain (procaspase-3, -6 and -7) exist in the cells as dimers that require proteolysis at internal aspartate residues to generate two large and two small subunits whose heterodimerization forms the active enzyme.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c110 : 1
stoichiometry:c109 : 1
stoichiometry:c111 : 1
m28*m79*0.1
nodelay
--
0
PMID: 17905508, 12966146 This limited phosphorylation induces the covalent dimerization of the receptor through disulfide binding, which activates a second wave of tyrosine phosphorylation of the receptor and its interaction with downstream signaling molecules that include phosphatidylinositol- 3-kinases, extracellular-signal-related kinases and Src kinases.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c112 : 1
stoichiometry:c115 : 1
stoichiometry:c116 : 1
m1839*m45*0.1
nodelay
--
0
PMID: 17905508 Activation of specific caspases in response to Epo in erythroid precursors leads to the specific cleavage of cellular targets such as PARP1, Acinus and Lamin B whereas the key differentiation- involved transcription factor GATA-1 is protected from cleavage by HSP70.
p42
p42
cso30:i:ME_Cleavage
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c113 : 1
stoichiometry:c117 : 1
stoichiometry:c118 : 1
m1839*m70781*0.1
nodelay
--
0
PMID: 17905508 Activation of specific caspases in response to Epo in erythroid precursors leads to the specific cleavage of cellular targets such as PARP1, Acinus and Lamin B whereas the key differentiation- involved transcription factor GATA-1 is protected from cleavage by HSP70.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c114 : 1
stoichiometry:c119 : 1
stoichiometry:c120 : 1
m1839*m46*0.1
nodelay
--
0
PMID: 17905508 Activation of specific caspases in response to Epo in erythroid precursors leads to the specific cleavage of cellular targets such as PARP1, Acinus and Lamin B whereas the key differentiation- involved transcription factor GATA-1 is protected from cleavage by HSP70.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c122 : 1
stoichiometry:c121 : 1
stoichiometry:c123 : 1
m2432*m79*0.1
nodelay
--
0
PMID: 17905508, 17047155 In response to M-CSF/CSF-1, procaspase-8 interacts with the adaptor molecule FADD (Fas- Associated Death Domain), the serine threonine kinase RIP1 and the long and short isoforms of FLIP.
p45
p45
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c124 : 1
stoichiometry:c126 : 1
stoichiometry:c127 : 1
stoichiometry:c128 : 1
stoichiometry:c131 : 1
stoichiometry:c129 : 1
m1814*m64*m2682*m2683*m66*0.1
nodelay
--
0
PMID: 17905508, 17047155 In response to M-CSF/CSF-1, procaspase-8 interacts with the adaptor molecule FADD (Fas- Associated Death Domain), the serine threonine kinase RIP1 and the long and short isoforms of FLIP.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c125 : 1
stoichiometry:c130 : 1
m63*0.1
nodelay
--
0
PMID: 17905508 Caspase-8 is activated in response to M-CSF that induces the formation of a multimolecular platform in which FADD, RIP1 and FLIP were identified.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c132 : 1
stoichiometry:c133 : 1
stoichiometry:c134 : 1
stoichiometry:c154 : 1
stoichiometry:c155 : 1
m65*0.1
nodelay
--
0
PMID: 17905508 Interestingly, RIP1 is cleaved by caspase-8 in the multimolecular platform. PMID: 17905508, 17047155, 12393560 We also observed that another well identified caspase target, Lamin B, remained uncleaved whereas three other caspase targets, namely RIP1, FLIP and Acinus, were cleaved.
p48
p48
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c135 : 1
stoichiometry:c137 : 1
stoichiometry:c136 : 1
m69*0.1
nodelay
--
0
PMID: 17905508 The RIP1 cleavage generates a fragment that prevents the sustained activation of NF-kappaB, which is observed in monocytes undergoing differentiation into dendritic cells, and contributes to the down-regulation of NF-kappaB that characterizes the differentiation of monocytes into macrophage.
p49
p49
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c139 : 1
stoichiometry:c141 : 1
stoichiometry:c140 : 1
m2394*m1839*0.1
nodelay
--
0
PMID: 17905508 A cleavage fragment of RIP1, generated by active caspase-8, contributes to the down-regulation of NF-kappaB whereas caspase-3, activated downstream of caspase-8, cleaves other target proteins such as PAK2 and nucleophosmin that contribute to the differentiation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c12 : 1
stoichiometry:c13 : 1
stoichiometry:c17 : 1
m6*m12*0.1
nodelay
--
0
PMID: 17905508 those with a short prodomain (procaspase-3, -6 and -7) exist in the cells as dimers that require proteolysis at internal aspartate residues to generate two large and two small subunits whose heterodimerization forms the active enzyme.
p50
p50
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c142 : 1
stoichiometry:c144 : 1
stoichiometry:c143 : 1
m22786*m1839*0.1
nodelay
--
0
PMID: 17905508 A cleavage fragment of RIP1, generated by active caspase-8, contributes to the down-regulation of NF-kappaB whereas caspase-3, activated downstream of caspase-8, cleaves other target proteins such as PAK2 and nucleophosmin that contribute to the differentiation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c145 : 1
stoichiometry:c148 : 1
stoichiometry:c149 : 1
m65*m3822*0.1
nodelay
--
0
PMID: 17905508, 16636047 This approach, performed in the U937 cell line model, identified several proteins whose caspase-mediated cleavage was confirmed in primary monocytes exposed to M-CSF. These target proteins include p21-activated kinase-2, Nucleophosmin, a-Tubulin, Vinculin, Plasminogen Activator Inhibitory-2 (PAI-2), and several proteins of the hnRNP family.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c146 : 1
stoichiometry:c152 : 1
stoichiometry:c150 : 1
m65*m4841*0.1
nodelay
--
0
PMID: 17905508, 16636047 This approach, performed in the U937 cell line model, identified several proteins whose caspase-mediated cleavage was confirmed in primary monocytes exposed to M-CSF. These target proteins include p21-activated kinase-2, Nucleophosmin, a-Tubulin, Vinculin, Plasminogen Activator Inhibitory-2 (PAI-2), and several proteins of the hnRNP family.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c147 : 1
stoichiometry:c153 : 1
stoichiometry:c151 : 1
m65*m76*0.1
nodelay
--
0
PMID: 17905508, 16636047 This approach, performed in the U937 cell line model, identified several proteins whose caspase-mediated cleavage was confirmed in primary monocytes exposed to M-CSF. These target proteins include p21-activated kinase-2, Nucleophosmin, a-Tubulin, Vinculin, Plasminogen Activator Inhibitory-2 (PAI-2), and several proteins of the hnRNP family.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c156 : 1
stoichiometry:c157 : 1
m44*0.1
nodelay
--
0
PMID: 17905508, 12966146 This limited phosphorylation induces the covalent dimerization of the receptor through disulfide binding, which activates a second wave of tyrosine phosphorylation of the receptor and its interaction with downstream signaling molecules that include phosphatidylinositol- 3-kinases, extracellular-signal-related kinases and Src kinases.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c158 : 1
stoichiometry:c159 : 1
stoichiometry:c160 : 1
m80*m79*0.1
nodelay
--
0
PMID: 17905508, 12966146 This limited phosphorylation induces the covalent dimerization of the receptor through disulfide binding, which activates a second wave of tyrosine phosphorylation of the receptor and its interaction with downstream signaling molecules that include phosphatidylinositol- 3-kinases, extracellular-signal-related kinases and Src kinases.
p56
p56
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c161 : 1
stoichiometry:c165 : 1
stoichiometry:c162 : 1
m2394*m4251*0.1
nodelay
--
0
PMID: 17905508 PAK-2 can be activated by the monomeric G proteins Cdc42 and Rac that, in their GTP-bound state, bind to a conserved region within the Nterminal domain of PAKs to release inhibition of the catalytic site by an overlapping autoinhibitory domain.
p57
p57
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c163 : 1
stoichiometry:c166 : 1
stoichiometry:c164 : 1
m2394*m84*0.1
nodelay
--
0
PMID: 17905508 PAK-2 can be activated by the monomeric G proteins Cdc42 and Rac that, in their GTP-bound state, bind to a conserved region within the Nterminal domain of PAKs to release inhibition of the catalytic site by an overlapping autoinhibitory domain.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c27 : 1
stoichiometry:c167 : 1
stoichiometry:c168 : 1
m15*m1814*0.1
nodelay
--
0
PMID: 17905508 Interaction of a death receptor such as Fas (CD95), with its ligand, triggers formation of a death-inducing signaling complex (DISC), including the adaptor molecule FADD, which in turn recruits procaspase-8.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c14 : 1
stoichiometry:c15 : 1
stoichiometry:c18 : 1
m13*m16*0.1
nodelay
--
0
PMID: 17905508 those with a short prodomain (procaspase-3, -6 and -7) exist in the cells as dimers that require proteolysis at internal aspartate residues to generate two large and two small subunits whose heterodimerization forms the active enzyme.
p7
p7
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c80 : 1
stoichiometry:c82 : 1
stoichiometry:c81 : 1
m2433*m21*0.1
nodelay
--
0
PMID: 17905508, 14976035, 12438425, 11208865 Caspase-3, together with caspase-9, -7 and -2, are transiently activated during erythroid differentiation induced by Epo and caspase inhibition completely inhibits erythroid differentiation at the basophilic erythroblast stage.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c23 : 1
stoichiometry:c31 : 1
stoichiometry:c48 : 1
m17*0.1
nodelay
--
0
PMID: 17905508 Procaspase-8 is then activated by proximity-induced dimerization within this oligomeric recruitment complex, which in turn activates the caspase cascade.
p9
p9
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c24 : 1
stoichiometry:c37 : 1
m2563*0.1
nodelay
--
0
PMID: 17905508 One of the soluble molecules subsequently released in the cytosol is cytochrome c, which induces Apaf-1 (apoptotic protease-activating factor 1) oligomerization and procaspase-9 recruitment and activation in the so-called apoptosome.
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--